Posted by Michael Wonder on 05 Apr 2024
Bausch Health Canada announces first public drug plan listings for Uceris (budesonide) aerosol foam to help address the unmet need for the treatment of mild to moderate distal ulcerative colitis in adults
3 April 2024 - Bausch Health Canada today announced the first public drug plan listings for Uceris (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults.
Uceris is now available for patients through the public drug plans of five Canadian provinces: Ontario, Quebec, Saskatchewan, New Brunswick and Nova Scotia.
